Cite
MLA Citation
T. Yamashita et al.. “1955 Primary systemic therapy by dual HER2 blockage with lapatinib (La) + trastuzumab (T) for Japanese patients (pts) with HER2+ breast cancer (BC): Association of La toxicity and dose with treatment efficacy.” European journal of cancer, vol. 51, n.d., pp. S317–S318. http://access.bl.uk/ark:/81055/vdc_100030628182.0x000053